IBDEI1SD ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31911,1,4,0)
 ;;=4^Z80.8
 ;;^UTILITY(U,$J,358.3,31911,2)
 ;;=^5063356
 ;;^UTILITY(U,$J,358.3,31912,0)
 ;;=Z81.8^^190^1944^34
 ;;^UTILITY(U,$J,358.3,31912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31912,1,3,0)
 ;;=3^Family Hx of Mental/Behavioral Disorders
 ;;^UTILITY(U,$J,358.3,31912,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,31912,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,31913,0)
 ;;=Z82.3^^190^1944^40
 ;;^UTILITY(U,$J,358.3,31913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31913,1,3,0)
 ;;=3^Family Hx of Stroke
 ;;^UTILITY(U,$J,358.3,31913,1,4,0)
 ;;=4^Z82.3
 ;;^UTILITY(U,$J,358.3,31913,2)
 ;;=^5063367
 ;;^UTILITY(U,$J,358.3,31914,0)
 ;;=Z82.49^^190^1944^25
 ;;^UTILITY(U,$J,358.3,31914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31914,1,3,0)
 ;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
 ;;^UTILITY(U,$J,358.3,31914,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,31914,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,31915,0)
 ;;=Z82.5^^190^1944^17
 ;;^UTILITY(U,$J,358.3,31915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31915,1,3,0)
 ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
 ;;^UTILITY(U,$J,358.3,31915,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,31915,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,31916,0)
 ;;=Z82.61^^190^1944^16
 ;;^UTILITY(U,$J,358.3,31916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31916,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,31916,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,31916,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,31917,0)
 ;;=Z82.69^^190^1944^35
 ;;^UTILITY(U,$J,358.3,31917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31917,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
 ;;^UTILITY(U,$J,358.3,31917,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,31917,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,31918,0)
 ;;=Z83.3^^190^1944^23
 ;;^UTILITY(U,$J,358.3,31918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31918,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,31918,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,31918,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,31919,0)
 ;;=Z83.2^^190^1944^19
 ;;^UTILITY(U,$J,358.3,31919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31919,1,3,0)
 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
 ;;^UTILITY(U,$J,358.3,31919,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,31919,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,31920,0)
 ;;=Z82.71^^190^1944^38
 ;;^UTILITY(U,$J,358.3,31920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31920,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,31920,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,31920,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,31921,0)
 ;;=Z82.1^^190^1944^18
 ;;^UTILITY(U,$J,358.3,31921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31921,1,3,0)
 ;;=3^Family Hx of Blindness/Visual Loss
 ;;^UTILITY(U,$J,358.3,31921,1,4,0)
 ;;=4^Z82.1
 ;;^UTILITY(U,$J,358.3,31921,2)
 ;;=^5063365
 ;;^UTILITY(U,$J,358.3,31922,0)
 ;;=Z82.2^^190^1944^22
 ;;^UTILITY(U,$J,358.3,31922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31922,1,3,0)
 ;;=3^Family Hx of Deafness/Hearing Loss
 ;;^UTILITY(U,$J,358.3,31922,1,4,0)
 ;;=4^Z82.2
 ;;^UTILITY(U,$J,358.3,31922,2)
 ;;=^5063366
 ;;^UTILITY(U,$J,358.3,31923,0)
 ;;=Z84.0^^190^1944^39
 ;;^UTILITY(U,$J,358.3,31923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31923,1,3,0)
 ;;=3^Family Hx of Skin Diseases
 ;;^UTILITY(U,$J,358.3,31923,1,4,0)
 ;;=4^Z84.0
 ;;^UTILITY(U,$J,358.3,31923,2)
 ;;=^5063388
 ;;^UTILITY(U,$J,358.3,31924,0)
 ;;=Z82.79^^190^1944^21
 ;;^UTILITY(U,$J,358.3,31924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31924,1,3,0)
 ;;=3^Family Hx of Congen Malform,Deformations & Chromsoml Abnlt
